134 related articles for article (PubMed ID: 7510900)
1. [Autotransplantation in acute leukemia using totipotent cells mobilized with filgrastim].
Ruiz-Argüelles GJ; Ruiz-Argüelles A; Alemán-Hoey DD; Arizpe Bravo D; Martin-López A; Ocejo Rodríguez A
Rev Invest Clin; 1993; 45(5):479-80. PubMed ID: 7510900
[No Abstract] [Full Text] [Related]
2. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
Carella AM
Haematologica; 1992; 77(4):348-51. PubMed ID: 1358772
[No Abstract] [Full Text] [Related]
3. Two-color flow cytometric analysis of CD34-positive peripheral blood stem cells mobilized by recombinant human granulocyte-colony stimulating factor for autotransplantation.
Inaba T; Shimazaki C; Ashihara E; Ohkawa K; Oku N; Gotoh H; Fujita N; Tsuji H; Nakagawa M
Prog Clin Biol Res; 1992; 377():561-7. PubMed ID: 1279725
[No Abstract] [Full Text] [Related]
4. Comparison of the collection efficiency and characteristics of peripheral blood progenitor cells mobilized by G-CSF administration in the steady state versus postmyelosuppressive chemotherapy.
Masauzi N; Kobayashi N; Suzuki G; Ohizumi H; Ogasawara M; Kiyama Y; Naohara T; Saitoh M; Higa T; Kasai M
Transplant Proc; 1996 Jun; 28(3):1741-5. PubMed ID: 8658864
[No Abstract] [Full Text] [Related]
5. Effects of rhG-CSF (filgrastim) on the recovery of hematopoiesis after high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
Suzue T; Takaue Y; Watanabe A; Kawano Y; Watanabe T; Abe T; Kuroda Y; Matsushita T; Kikuta A; Iwai A
Exp Hematol; 1994 Nov; 22(12):1197-202. PubMed ID: 7523170
[TBL] [Abstract][Full Text] [Related]
6. [Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies].
Qiu HY; Wu DP; Sun AN; Chang WR; Jin ZM; Miao M; Tang XW; Shen YM; Fu ZZ
Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):462-5. PubMed ID: 15555260
[TBL] [Abstract][Full Text] [Related]
7. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
[TBL] [Abstract][Full Text] [Related]
8. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
9. Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration.
Kawano C; Muroi K; Kuribara R; Matsumoto Y; Ohtsuki T; Hatake K; Ozawa K
Bone Marrow Transplant; 2000 Jan; 25(2):228-9. PubMed ID: 10673691
[No Abstract] [Full Text] [Related]
10. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
11. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphoma.
Martínez C; Mateu R; Sureda A; Brunet S; Amill B; Madoz P; Portos JM; Subirà M; García-López J; Domingo-Albós A
Transplant Proc; 1995 Aug; 27(4):2355-6. PubMed ID: 7544503
[No Abstract] [Full Text] [Related]
13. Successful second autologous blood stem cell transplantation after G-CSF-combined conditioning for the treatment of high-risk acute myelogenous leukemia.
Takamatsu Y; Teshima T; Akashi K; Inaba S; Harada M; Niho Y
Bone Marrow Transplant; 1994 Mar; 13(3):325-7. PubMed ID: 7515302
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies.
Sheridan WP; Begley CG; To LB; Grigg A; Szer J; Maher D; Green MD; Rowlings PA; McGrath KM; Cebon J
Bone Marrow Transplant; 1994 Jul; 14(1):105-11. PubMed ID: 7524904
[TBL] [Abstract][Full Text] [Related]
15. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.
Carella AM; Podesta M; Frassoni F; Raffo MR; Pollicardo N; Pungolino E; Vimercati R; Sessarego M; Parodi C; Rabitti C
Bone Marrow Transplant; 1993 Sep; 12(3):267-71. PubMed ID: 7694724
[TBL] [Abstract][Full Text] [Related]
16. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood progenitors mobilised by G-CSF (filgrastim) and reinfused as unprocessed autologous whole blood shorten the pancytopenic period following high-dose melphalan in multiple myeloma.
Ossenkoppele GJ; Jonkhoff AR; Huijgens PC; Nauta JJ; van der Hem KG; Dräger AM; Langenhuijsen MM
Bone Marrow Transplant; 1994 Jan; 13(1):37-41. PubMed ID: 7517255
[TBL] [Abstract][Full Text] [Related]
18. The role of peripheral blood stem cells as rescue after myeloablative therapy.
Reiffers J; Marit G; Boiron JM; Rice A; Bernard P; Vezon G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():212-4. PubMed ID: 2565746
[No Abstract] [Full Text] [Related]
19. Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation.
Shimazaki C; Oku N; Uchiyama H; Yamagata N; Tatsumi T; Hirata T; Ashihara E; Okawa K; Goto H; Inaba T
Bone Marrow Transplant; 1994 Mar; 13(3):271-5. PubMed ID: 7515300
[TBL] [Abstract][Full Text] [Related]
20. [Hematological recovery after peripheral blood stem cell transplantation followed by recombinant granulocyte colony-stimulating factor].
Fujii H; Nakagawa H; Sonoda Y; Kuzuyama Y
Rinsho Ketsueki; 1993 Aug; 34(8):904-11. PubMed ID: 7692115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
